Medical Devices · Healthcare
Board Member
2026-06-10–present
Board Member
Alphatec Holdings, Inc. (ATEC)Equibles does not estimate personal net worth.
Get an email with a short summary when Alphatec Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get ATEC alertsDavid Demski is recorded as Board Member at Alphatec Holdings, Inc. (ATEC) since June 10, 2026. David Demski was last confirmed as CEO at Globus Medical Inc (GMED) in a filing dated April 28, 2023. Earlier roles on record: CEO at Globus Medical Inc (GMED) until April 21, 2022 and Board Member at Globus Medical Inc (GMED) until April 20, 2022. Alphatec Holdings, Inc. reported in an 8-K filed June 11, 2026 that David Demski was appointed Director, effective June 10, 2026. Alphatec Holdings, Inc. reported in an 8-K filed June 17, 2024 that David Demski was appointed director, effective June 12, 2024. The proxy statement of Globus Medical Inc reports total compensation of $4,737,281 for David Demski in fiscal 2022, including a base salary of $513,446. Disclosed compensation is on record for 6 fiscal years. David Demski has spoken on 3 earnings calls across 1 company, most recently for Globus Medical Inc on February 17, 2022. Alphatec Holdings, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other companies whose calls David Demski spoke on are classified in the Healthcare sector. Other leadership on record at Alphatec Holdings, Inc. includes J. Todd Koning (CFO), Todd Koning (CFO), Scott Lish (COO) and 7 others.
“The stockholders elected each of Mortimer Berkowitz III, Quentin Blackford, David Demski, Karen K. McGinnis, Patrick S. Miles, David R. Pelizzon, and Keith Valentine to serve on the Company’s Board of Directors for a term of one year until the 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified, or until their earlier death or resignation, by the following vote:”
“The stockholders elected each of Evan Bakst, Mortimer Berkowitz III, Quentin Blackford, David Demski, Karen K. McGinnis, Patrick S. Miles, David R. Pelizzon, Jeffrey P. Rydin, and Ward W. Woods to serve on the Company’s Board of Directors for a term of one year until the 2025 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified, or until their earlier death or resignation, by the following vote:”
“Well, thank you, Brian, and good afternoon, everyone. Globus finished an outstanding 2021 with a strong fourth quarter performance. Revenue for the year was a record $958 million, an increase of 21% over 2020 or $169 million in growth.”
“From a market standpoint, Q1, we're definitely feeling COVID restrictions. Q2 from what we can see right now, it looks like the impact would be modestly negative.”
“No, Rich, I'm just being specific there, I want to be specific, that's U.S. spinal implant business.”
2026-06-10–present
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
Start not stated–2022-04-20
Start not stated–2022-04-21
Medical Devices · Healthcare
Board Member
2026-06-10–present
GMED
Medical Devices · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Globus Medical Inc (GMED) | Chief Executive Officer and President (until April 2022) | $513,446 | $4,737,281 |
| 2021 | Globus Medical Inc (GMED) | Chief Executive Officer and President (until April 2022) | $498,490 | $5,088,592 |
| 2020 | Globus Medical Inc (GMED) | Chief Executive Officer and President (until April 2022) | $483,972 | $4,026,977 |
| 2019 | Globus Medical Inc (GMED) | Chief Executive Officer and President | $469,875 | $3,449,794 |
| 2018 | Globus Medical Inc (GMED) | Chief Executive Officer and President | $456,190 | $3,394,012 |
| 2017 | Globus Medical Inc (GMED) | Chief Executive Officer and President | $396,483 | $4,451,524 |